CG
PBH icon

Caprock Group’s Prestige Consumer Healthcare PBH Stock Holding History

Caprock Group’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$239K Buy
2,775
+87
+3% +$7.14K 0.01% 950
2024
Q4 		$210K Buy
+2,688
New +$209K 0.01% 925
2016
Q4 		– Sell
-4,341
Closed -$210K – 379
2016
Q3 		$210K Buy
+4,341
New +$220K 0.05% 324

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caprock Group's PBH Position: Q1 2025 in Review

Caprock Group increased its Prestige Consumer Healthcare (PBH) stake by 3.2% in Q1 2025, buying an estimated $7.14K and bringing the position to 2,775 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #950.

Caprock Group first reported a position in PBH in Q3 2016 and has held it in 3 quarters since. 359 funds tracked by Wall St. Rank hold PBH as of Q1 2025.

  • Caprock Group held 2,775 shares of Prestige Consumer Healthcare worth $239K as of Q1 2025.
  • Caprock Group bought 87 Prestige Consumer Healthcare shares in Q1 2025, an estimated $7.14K.
  • Prestige Consumer Healthcare made up 0.01% of Caprock Group's portfolio in Q1 2025, its #950 holding.
  • Caprock Group first reported a position in Prestige Consumer Healthcare in Q3 2016 and has held it in 3 quarters since.
  • 359 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2025.

Based on Caprock Group's 13F filing for Q1 2025, filed 15 May 2025.